Anthracycline metabolites from Streptomyces violaceus A262. IV. New anthracycline yellamycins produced by a variant strain SC-7.
Johdo
O
O
Central Research Laboratories, Mercian Corporation, Fujisawa, Japan.
Tone
H
H
Okamoto
R
R
Yoshimoto
A
A
Naganawa
H
H
Sawa
T
T
Takeuchi
T
T
D000818:Animals; D018943:Anthracyclines; D000903:Antibiotics, Antineoplastic / Q000737:chemistry / Q000302:isolation & purification / Q000494:pharmacology*; D004273:DNA, Neoplasm / Q000096:biosynthesis; D005285:Fermentation; D007939:Leukemia L1210 / Q000188:drug therapy; D009682:Magnetic Resonance Spectroscopy; D051379:Mice; D015394:Molecular Structure; D012334:RNA, Neoplasm / Q000096:biosynthesis; D013302:Streptomyces / Q000378:metabolism*; D014407:Tumor Cells, Cultured / Q000187:drug effects
D018943:Anthracyclines; D000903:Antibiotics, Antineoplastic; D004273:DNA, Neoplasm; D012334:RNA, Neoplasm; C071811:yellamycin B; C071810:yellamycin A; C071812:yellamycin C